Cardiol Therapeutics
Across other SEC filings
Federal lobbying
Spend, trailing 12 months
$40.0K
Through Q2 2023, from quarterly LD-2 reports
Cardiol Therapeutics lobbying profile
Ownership explorer
Loading ownership explorer…
Security Details
| CUSIP | 14161Y900 |
|---|---|
| Type | Option |
| Company | Cardiol Therapeutics |
Other securities from this issuer
| Name | Symbol | CUSIP | Type |
|---|---|---|---|
| CARDIOL THERAPEUTICS INC-A | CRDL | 14161Y200 | Common stock |
Identifier History
| Type | Value | From | To |
|---|---|---|---|
| CUSIP | 14161Y900 | 2021-12-31 | Current |